Anya Harry

Dr. Anya Harry is the Global Lead for Clinical Trial Diversity at GlaxoSmithKline. Her passion for this area evolved from her experiences in clinical care, public health and drug development and research.

Previously, Anya was a Director in Clinical Development providing leadership and medical support for early as well as late stage programs and device initiatives in the Respiratory Therapeutic Area.